Correlation of hypothyroidism with survival in metastatic renal cancer patients treated with sorafenib or sunitinib

被引：0
|
作者：
Riesenbeck, L.
Bierer, S.
Hoffmeister, I.
Koepke, T.
Hertle, L.
Thielen, B.
Herrmann, E.
机构：
[1] Univ Hosp Muenster, Munster, Germany
[2] Univ Munster, D-48149 Munster, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.379
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
379
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
    Riesenbeck, L. M.
    Bierer, S.
    HoVmeister, I.
    Koepke, T.
    Papavassilis, P.
    Hertle, L.
    Thielen, B.
    Herrmann, E.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (06) : 807 - 813
  • [2] Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
    L. M. Riesenbeck
    S. Bierer
    I. Hoffmeister
    T. Köpke
    P. Papavassilis
    L. Hertle
    B. Thielen
    E. Herrmann
    World Journal of Urology, 2011, 29 : 807 - 813
  • [3] Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer
    Theofanis Vasileiadis
    Michail Chrisofos
    Michail Safioleas
    Konstantinos Kontzoglou
    Konstantinos Papazisis
    Athina Sdrolia
    BMC Cancer, 19
  • [4] mpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer
    Vasileiadis, Theofanis
    Chrisofos, Michail
    Safioleas, Michail
    Kontzoglou, Konstantinos
    Papazisis, Konstantinos
    Sdrolia, Athina
    BMC CANCER, 2019, 19 (1)
  • [5] Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Rini, Brian I.
    Tamaskar, Ila
    Shaheen, Phillip
    Salas, Renee
    Garcia, Jorge
    Wood, Laura
    Reddy, Sethu
    Dreicer, Robert
    Bukowski, Ronald M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (01): : 81 - 83
  • [6] Validation of MSKCC-criteria in metastatic renal cancer patients treated with sorafenib or sunitinib
    Hoffmeister, I.
    Riesenbeck, L.
    Bierer, S.
    Koepke, T.
    Hertle, L.
    Thielen, B.
    Herrmann, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Feldman, Darren R.
    Martorella, Andrew J.
    Robbins, Richard J.
    Motzer, Robert J.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 974 - 975
  • [8] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Garfield, David H.
    Hercbergs, Aleck
    Davis, Paul J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12): : 975 - 976
  • [9] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib - Response
    Rini, Brian I.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) : 976 - 977
  • [10] Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer
    Xin Ma
    Lei Wang
    Hongzhao Li
    Yu Zhang
    Yu Gao
    Gang Guo
    Kan Liu
    Qingyu Meng
    Chaofei Zhao
    Dianjun Wang
    Zhigang Song
    Xu Zhang
    Scientific Reports, 6
12345